Meeting
2016 Genitourinary Cancers Symposium
Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.
Authors
Jonathan So
Princess Margaret Cancer Centre, Toronto, ON, Canada
Jonathan So , Melvin Chua , Emilie Lalonde , Osman Mahamud , Alejandro Berlin , Alan Dal Pra , Michèle Orain , Helene Hovington , Alain Bergeron , Yves Fradet , Bernard Têtu , Alice Meng , Junyan Zhang , Gaetano Zafarana , Julie Livingstone , Melania Pintilie , Theodorus van der Kwast , Michael Fraser , Paul Boutros , Robert G. Bristow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 49)
DOI
10.1200/jco.2016.34.2_suppl.49
Abstract #
49
Poster Bd #
C9
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.
First Author: Melvin Chua
Poster
2017 Genitourinary Cancers Symposium
Validation of GEMCaP as a DNA based biomarker to predict disease recurrence in patients undergoing prostatectomy for prostate cancer.
First Author: Hao Gia Nguyen
Poster
2016 Genitourinary Cancers Symposium
Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence.
First Author: Stacy Loeb
Poster
2016 Genitourinary Cancers Symposium
Copy number alterations of P53, RB1, and MDM2 as prognostic markers in intermediate-risk prostate cancer.
First Author: Osman Mahamud